Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer

Clinical trial NCT00970502 · COMPLETED

Trial details

NCT number: NCT00970502
Sponsor: Johnny Kao
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer of the Pharynx Cancer of the Larynx Cancer of the Neck Paranasal Sinus Neoplasms Cancer of the Head

Start date: 2007-02-01
Primary completion: 2010-11-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.